Pharma

Five things for pharma marketers to know: Friday, January 20, 2017

Five things for pharma marketers to know: Friday, January 20, 2017

By

Pharma among top sponsors of Trump inauguration parties; AstraZeneca exec to replace GSK president of global pharmaceuticals; EpiPen rival to relaunch

Five things for pharma marketers to know: Wednesday, January 18, 2017

Five things for pharma marketers to know: Wednesday, January 18, 2017

By

Rep. Price to answer questions at confirmation hearing; 22 drugmakers invest in fighting disease in poor countries; FDA approves generic of Jazz's Xyrem

Industry hires and promotions: January 2017

Industry hires and promotions: January 2017

By

Endo hires new head of U.S. branded pharma, and three other people moves for you to know about.

Five things for pharma marketers to know: Thursday, January 12, 2017

Five things for pharma marketers to know: Thursday, January 12, 2017

By

Trump says pharma is "getting away with murder"; Senate majority votes to repeal ACA; IBM Watson Health and FDA to study blockchain technology

Infographic: Can pharma give doctors what they want?

Infographic: Can pharma give doctors what they want?

Physicians do not like EHRs. That much is clear. But the vast majority have to use electronic record systems on a daily basis. What can pharma do to better give doctors what they want?

Day 1 at JP Morgan: Pricing is top of mind for pharma CEOs

Day 1 at JP Morgan: Pricing is top of mind for pharma CEOs

By

The questions being asked about how drugs are priced are weighing heavily on pharma leaders, and they know the issue is not going away.

Five things for pharma marketers to know: Wednesday, January 4, 2017

Five things for pharma marketers to know: Wednesday, January 4, 2017

By

Sanofi, Regeneron denied bid to overturn Amgen win in patent case; Abbott to close St. Jude deal; Gilead hires SVP of hematology and oncology

Why healthbots may eat search ads and mobile apps

Why healthbots may eat search ads and mobile apps

By

The internet strongly agrees there's an artificial intelligence revolution going on, and it's come to pharma marketing.

MM&M's new logo reflects the evolving industry

MM&M's new logo reflects the evolving industry

By

This month we will debut a restyled MM&M logo on our website, in a mobile-friendly, redesigned email newsletter, and on the cover of our magazine.

Drugmakers: Take a Note From P&G, and Generate Some Goodwill

Drugmakers: Take a Note From P&G, and Generate Some Goodwill

We, as an industry, frighten rather than inform, cover our butts rather than support, and confuse rather than encourage.

MM&M launches search for 2017 Healthcare Transformers

MM&M launches search for 2017 Healthcare Transformers

By

It is also seeking industry input for a new category of honoree, the Top 10 Innovation Catalysts.

Five things for pharma marketers to know: Friday, December 9, 2016

Five things for pharma marketers to know: Friday, December 9, 2016

By

BMS to pay $19.5 million to settle marketing violations for Abilify; AstraZeneca to cut 700 U.S. jobs; Trump reportedly considering Jim O'Neill to lead FDA

An EHR strategy can't be measured in clicks, says Lilly exec

An EHR strategy can't be measured in clicks, says Lilly exec

By

Pharma can reach physicians within the EHR, but they must send the right message at the right time, she said at an MM&M event.

MM&M's top 5 stories in November 2016

MM&M's top 5 stories in November 2016

By

How VR, nanotechnology, and 3D printing could improve the value of healthcare; 100 experimental therapies in late-stage clinical trials; Kite Pharma plans "controlled" launch of CAR-T therapy

The New Reality for Pharma Marketers is Drug Pricing

The New Reality for Pharma Marketers is Drug Pricing

By

My hope is that all of us do a better job of focusing on value.

Gilead's Meyers on making deals and finding unmet patient needs

Gilead's Meyers on making deals and finding unmet patient needs

By

The drugmaker's new EVP of worldwide commercial operations also talks about tackling medication access, product launches, and starting a commercial team from scratch.

Five things for pharma marketers to know: Monday, November 28, 2016

Five things for pharma marketers to know: Monday, November 28, 2016

By

J&J in talks to buy Actelion; Novo Nordisk pulls ads on Breitbart News; Takeda to market Ninlaro in Europe

Five things for pharma marketers to know: Thursday, November 17, 2016

Five things for pharma marketers to know: Thursday, November 17, 2016

By

Former Valeant and Philidor execs arrested; at least 1 million enroll in 2017 exchange plans; mobile game helps scientists study dementia

Will he or won't he? Pharma speculates on President-elect Trump

Will he or won't he? Pharma speculates on President-elect Trump

By

If Trump decides to go after pharma, politicians aren't likely to receive too many "How can you do this? Think about the children!" notes.

Changing Behavior is Ongoing, And That's Why It Requires Communications

Changing Behavior is Ongoing, And That's Why It Requires Communications

As humans, we trade in the credits and debits of good and bad behavior. We break diets, we resume smoking, we forget our medicine.

Five things for pharma marketers to know: Wednesday, November 9, 2016

Five things for pharma marketers to know: Wednesday, November 9, 2016

By

Trump, a critic and supporter of pharma, wins election; pharma's futures rise in election's wake; drug-pricing measure in California likely to be defeated

Infographic: what information doctors need from pharma

Infographic: what information doctors need from pharma

How pharma distributes information to doctors is changing as rapidly as how doctors prefer to receive and process such information

The Highly Regulated Healthcare Industry Can Draw in Top Marketers

The Highly Regulated Healthcare Industry Can Draw in Top Marketers

Today's ambitious marketers and media people want to be the ones to not only figure out how to work within the regulations but also to create better work than ever before.

Five things for pharma marketers to know: Thursday, November 3, 2016

Five things for pharma marketers to know: Thursday, November 3, 2016

By

Sprout investors sue Valeant; FDA raises safety concerns for Cempra's experimental pneumonia drug; NHS gets approval to prescribe eribulin to breast cancer patients

Five things for pharma marketers to know: Wednesday, November 2, 2016

Five things for pharma marketers to know: Wednesday, November 2, 2016

By

Valeant to sell stomach-drug business for $10 billion; Pfizer reports growth in third quarter; sales of hep.-C drugs drive revenue down for Gilead Sciences

Timeline of a crisis: How Mylan responded to the EpiPen controversy

Timeline of a crisis: How Mylan responded to the EpiPen controversy

By

Mylan was slammed by people unable to afford its lifesaving EpiPen injection device following a price hike — its response was seen as too little, too late.

How We Picked the Health Influencer 50

How We Picked the Health Influencer 50

By

Each of this year's Influencers wields significant influence at a major health-related organization and boasts high-profile accomplishments, oftentimes ahead of the aforementioned pain-of- change curve.

Marvel creates superheroes suffering from bowel disease for Takeda campaign

Marvel creates superheroes suffering from bowel disease for Takeda campaign

By

Takeda launched four new superheroes whose lives have been touched by inflammatory bowel disease (IBD), with the help of PR agency Ketchum.

Astellas boosts pharma's rep with corporate branding push

Astellas boosts pharma's rep with corporate branding push

By

The new TV spot was developed with CNN and Edelman.

Drugmakers spar with FDA over proposed DTC animation study

Drugmakers spar with FDA over proposed DTC animation study

By

The FDA responded to criticism from industry about its proposed research of DTC animation.

OPINION

Email Newsletters